This is the authors' abstract. We don't add key points for this paper.
. VA reversed these changes back to normal levels to varying degrees. Metabolomic profiling demonstrated that VA treatment was efficacious in modulating several key liver metabolites involved in neuroactive ligand-receptor interaction, prolactin signaling pathway, estrogen signaling pathway, and glutathione metabolism. Conclusively, VA may ameliorate liver damage and suppress the fibrogenesis caused by thioacetamide by correcting intestinal microbiota disorders and promoting normal hepatic metabolism. This research provides a novel perspective on vanillic acid as a dietary supplement for hepatic fibrosis improvement.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: